Company Info
Year Established2018
Contacts
Kevin O'NeillCEO
Matthijs Schoots
Head of Strategic Planning
Pedro Garbes, MD.
Global Medical Lead
Company Description
Uvax Bio employs proprietary 1c-SApNP platform technology to develop and commercialize prophylactic vaccines for the most challenging infectious diseases.